SECURITIES AND EXCHANGE COMMISSION
THE SECURITIES ACT OF 1933
| | Delaware (State or Other Jurisdiction of Incorporation or Organization) | | | 4911 (Primary Standard Industrial Classification Code Number) | | | 86-2292473 (I.R.S. Employer Identification No.) | |
Santa Clara, California 95054 (650) 550-0127
Oklo Inc.
3190 Coronado Dr.
Santa Clara, California 95054 (650) 550-0127
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, Texas 77002
(713) 546 -5400
| | Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| | Non-accelerated filer ☒ | | | Smaller reporting company ☒ | |
| | Emerging growth company ☒ | | | ||
| | | | Page | | |||
| | | | | i | | | |
| | | | | ii | | | |
| | | | | iv | | | |
| | | | | 1 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 41 | | | |
| | | | | 42 | | | |
| | | | | 43 | | | |
| | | | | 44 | | | |
| | | | | 59 | | | |
| | | | | 66 | | | |
| | | | | 73 | | | |
| | | | | 79 | | | |
| | | | | 81 | | | |
| | | | | 82 | | | |
| | | | | 84 | | | |
| | | | | 87 | | | |
| | | | | 92 | | | |
| | | | | 94 | | | |
| | | | | 94 | | | |
| | | | | 94 | | | |
| | | | | F-1 | | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| | | | (in thousands) | | |||||||||
| Net cash used in operating activities | | | | $ | (38,390) | | | | | $ | (15,998) | | |
| Net cash used in investing activities | | | | | (175,774) | | | | | | (83) | | |
| Net cash provided by financing activities | | | | | 301,428 | | | | | | 16,295 | | |
| Net increase in cash and cash equivalents | | | | $ | 87,264 | | | | | $ | 214 | | |
| Cash and cash equivalents, end of year | | | | $ | 97,132 | | | | | $ | 9,868 | | |
| | | | Years Ended December 31, | | | 2024 versus 2023 | | ||||||||||||||||||
| | | | 2024 | | | 2023 | | | $ Change | | | % Change | | ||||||||||||
| | | | (in thousands) | | |||||||||||||||||||||
| Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
| Research and development | | | | $ | 26,711 | | | | | $ | 9,763 | | | | | $ | 16,948 | | | | | | 173.6% | | |
| General and administrative | | | | | 26,090 | | | | | | 8,873 | | | | | | 17,217 | | | | | | 194.0% | | |
| Total operating expenses | | | | | 52,801 | | | | | | 18,636 | | | | | | 34,165 | | | | | | 183.3% | | |
| Loss from operations | | | | | (52,801) | | | | | | (18,636) | | | | | | (34,165) | | | | | | 183.3% | | |
| Other (income) loss | | | | | | | | | | | | | | | | | | | | | | | | | |
| Change in fair value of simple agreement for future equity | | | | | (27,864) | | | | | | (13,717) | | | | | | (14,147) | | | | | | 103.1% | | |
| Interest and dividend income | | | | | 7,732 | | | | | | 180 | | | | | | 7,552 | | | | | | NM | | |
| Total other loss | | | | | (20,132) | | | | | | (13,537) | | | | | | (6,595) | | | | | | 48.7% | | |
| Loss before income taxes | | | | | (72,933) | | | | | | (32,173) | | | | | | (40,760) | | | | | | 126.7% | | |
| Income taxes | | | | | (683) | | | | | | — | | | | | | (683) | | | | | | NM | | |
| Net loss | | | | $ | (73,616) | | | | | $ | (32,173) | | | | | $ | (41,443) | | | | | | 128.8% | | |
| | | | Years Ended December 31, | | | 2024 versus 2023 | | ||||||||||||||||||
| | | | 2024 | | | 2023 | | | $ Change | | | % Change | | ||||||||||||
| | | | (in thousands) | | |||||||||||||||||||||
| Total research and development expenses | | | | $ | 26,711 | | | | | $ | 9,763 | | | | | $ | 16,948 | | | | | | 173.6% | | |
| | | | Years Ended December 31, | | | 2024 versus 2023 | | ||||||||||||||||||
| | | | 2024 | | | 2023 | | | $ Change | | | % Change | | ||||||||||||
| | | | (in thousands) | | |||||||||||||||||||||
| Total research and development expenses | | | | $ | 26,090 | | | | | $ | 8,873 | | | | | $ | 17,217 | | | | | | 194.0% | | |
| | | | Years Ended December 31, | | | 2024 versus 2023 | | ||||||||||||||||||
| | | | 2024 | | | 2023 | | | $ Change | | | % Change | | ||||||||||||
| | | | (in thousands) | | |||||||||||||||||||||
| Change in fair value of SAFEs | | | | $ | (27,864) | | | | | $ | (13,717) | | | | | $ | (14,147) | | | | | | 103.1% | | |
| Interest and dividend income | | | | | 7,732 | | | | | | 180 | | | | | | 7,552 | | | | | | NM | | |
| Total other loss | | | | $ | (20,132) | | | | | $ | (13,537) | | | | | $ | (6,595) | | | | | | 48.7% | | |
| Name | | | Age | | | Position(s) | |
| Executive Officers: | | | | | | | |
| Jacob DeWitte | | | 39 | | | Chairman and Chief Executive Officer | |
| R. Craig Bealmear | | | 58 | | | Chief Financial Officer | |
| Caroline Cochran | | | 42 | | | Chief Operating Officer and Director | |
| Non-Employee Directors: | | | | | | | |
| Lieutenant General (Ret.) John Jansen(1)(2) | | | 62 | | | Director | |
| Richard W. Kinzley(1)(2) | | | 59 | | | Director | |
| Michael Klein(3) | | | 61 | | | Director | |
| Michael Thompson(2) | | | 48 | | | Director | |
| Daniel B. Poneman(3) | | | 69 | | | Director | |
| Name | | | Year | | | Salary ($) | | | Bonus ($) | | | Stock Awards ($)(1) | | | Option Awards ($)(2) | | | All Other Compensation ($) | | | Total ($) | | |||||||||||||||||||||
| Jacob DeWitte Co-Founder, Chief Executive Officer | | | | | 2024 | | | | | | 425,095 | | | | | | 587,548(3) | | | | | | 2,622,475 | | | | | | — | | | | | | 13,800(4) | | | | | | 3,648,918 | | |
| | | | 2023 | | | | | | 211,077 | | | | | | 112,000 | | | | | | — | | | | | | — | | | | | | 8,615 | | | | | | 331,692 | | | ||
| Caroline Cochran Co-Founder, Chief Operating Officer | | | | | 2024 | | | | | | 357,981 | | | | | | 278,990(3) | | | | | | 1,835,730 | | | | | | — | | | | | | 13,716(4) | | | | | | 2,486,417 | | |
| | | | 2023 | | | | | | 211,077 | | | | | | 112,000 | | | | | | — | | | | | | — | | | | | | 8,969 | | | | | | 332,046 | | | ||
| R. Craig Bealmear(5) Chief Financial Officer | | | | | 2024 | | | | | | 362,308 | | | | | | 281,154(3) | | | | | | 1,835,730 | | | | | | — | | | | | | 13,308(4) | | | | | | 2,492,500 | | |
| | | | 2023 | | | | | | 115,385 | | | | | | 62,500 | | | | | | — | | | | | | 3,015,873 | | | | | | 1,846 | | | | | | 3,195,604 | | | ||
| Named Executive Officer | | | Title | | | Annual Base Salary ($) | | | Initial Grant Target Grant Date Value ($) | | ||||||
| Jacob DeWitte | | | Chief Executive Officer | | | | | 500,000 | | | | | | 3,000,000 | | |
| Caroline Cochran | | | Chief Operating Officer | | | | | 400,000 | | | | | | 2,100,000 | | |
| R. Craig Bealmear | | | Chief Financial Officer | | | | | 400,000 | | | | | | 2,100,000 | | |
| | | | | | | | | | Option Awards | | | Stock Awards | | ||||||||||||||||||||||||||||||
| Name | | | Grant Date | | | Number of Securities Underlying Unexercised Options (#) Exercisable | | | Number of Securities Underlying Unexercised Options (#) Unexercisable | | | Option Exercise Price ($) | | | Option Expiration Date | | | Number of Shares or Units of Stock That Have Not Vested (#) | | | Market Value of Shares or Units of Stock That Have Not Vested ($) | | |||||||||||||||||||||
| Jacob DeWitte | | | | | 7/10/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 280,899(1) | | | | | | 5,963,486 | | |
| Caroline Cochran | | | | | 7/10/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 196,629(1) | | | | | | 4,174,434 | | |
| R. Craig Bealmear | | | | | 7/10/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 196,629(1) | | | | | | 4,174,434 | | |
| | | | | | 12/23/2023 | | | | | | 353,536 | | | | | | 972,223(2) | | | | | | 3.18 | | | | | | 12/23/2033 | | | | | | — | | | | | | — | | |
| Name | | | Fees Earned or Paid in Cash ($) | | | Stock Awards ($)(1) | | | Total ($) | | |||||||||
| Sam Altman(2) | | | | | — | | | | | | — | | | | | | — | | |
| Michael Klein(2) | | | | | — | | | | | | — | | | | | | — | | |
| Richard W. Kinzley | | | | | 58,104 | | | | | | 131,124 | | | | | | 189,228 | | |
| Lieutenant General (Ret.) John Jansen | | | | | 54,876 | | | | | | 131,124 | | | | | | 186,000 | | |
| Chris Wright | | | | | 45,192 | | | | | | 131,124 | | | | | | 176,316 | | |
| Name | | | Stock Awards Outstanding | | |||
| Sam Altman | | | | | — | | |
| Michael Klein | | | | | — | | |
| Richard W. Kinzley | | | | | 16,854 | | |
| Lieutenant General (Ret.) John Jansen | | | | | 16,854 | | |
| Chris Wright | | | | | 16,854 | | |
| Name and Address of Beneficial Owner(1) | | | Number of Shares | | | % of Ownership | | ||||||
| Directors and Named Executive Officers | | | | | | | | | | | | | |
| Jacob DeWitte(2) | | | | | 25,402,712 | | | | | | 18.24% | | |
| Caroline Cochran(2) | | | | | 25,402,712 | | | | | | 18.24% | | |
| Michael Klein(3) | | | | | 500,000 | | | | | | * | | |
| Richard W. Kinzley(4) | | | | | 21,854 | | | | | | * | | |
| R. Craig Bealmear(5) | | | | | 547,351 | | | | | | * | | |
| Lieutenant General (Ret.) John Jansen(6) | | | | | 22,854 | | | | | | * | | |
| Michael Thompson | | | | | — | | | | | | — | | |
| Daniel B. Poneman | | | | | — | | | | | | — | | |
| All directors and executive officers as a group (8 individuals) | | | | | 26,531,771 | | | | | | 18.96% | | |
| Name of Selling Holder and Addresses | | | Number of Shares of Common Stock Owned Prior to Offering | | | Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus | | | Number of Shares of Common Stock Owned After Offering | | | Percentage of Outstanding Common Stock Beneficially Owned After the Offered Shares of Common Stock are Sold | | ||||||||||||
| 8090 Industries Decarbonization Fund II LP | | | | | 23,046 | | | | | | 23,046 | | | | | | — | | | | | | — | | |
| AA13 L.L.C. | | | | | 1,427 | | | | | | 1,427 | | | | | | — | | | | | | — | | |
| Asymmetry Ventures Fund I, A Series of Asymmetry Ventures, LP | | | | | 3,172 | | | | | | 3,172 | | | | | | — | | | | | | — | | |
| At Fund I, A Series of Ax-Rn-Funds, LP | | | | | 43,607 | | | | | | 43,607 | | | | | | — | | | | | | — | | |
| Atypical LLC | | | | | 19,716 | | | | | | 19,716 | | | | | | — | | | | | | — | | |
| Atypical Ventures Fund I, L.P. | | | | | 27,684 | | | | | | 27,684 | | | | | | — | | | | | | — | | |
| Calvin French-Owen | | | | | 1,903 | | | | | | 1,903 | | | | | | — | | | | | | — | | |
| Chad Morris | | | | | 713 | | | | | | 713 | | | | | | — | | | | | | — | | |
| Christopher Robert Boshuizen | | | | | 3,569 | | | | | | 3,569 | | | | | | — | | | | | | — | | |
| Crunch Fund III, L.P. | | | | | 54,727 | | | | | | 54,727 | | | | | | — | | | | | | — | | |
| Data Collective IV, L.P. | | | | | 33,879 | | | | | | 33,879 | | | | | | — | | | | | | — | | |
| Divergent Capital I, L.P. | | | | | 57,105 | | | | | | 57,105 | | | | | | — | | | | | | — | | |
| Name of Selling Holder and Addresses | | | Number of Shares of Common Stock Owned Prior to Offering | | | Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus | | | Number of Shares of Common Stock Owned After Offering | | | Percentage of Outstanding Common Stock Beneficially Owned After the Offered Shares of Common Stock are Sold | | ||||||||||||
| At Fund II, A Series of Ax-Rn-Funds, LP | | | | | 5,673 | | | | | | 5,673 | | | | | | — | | | | | | — | | |
| Hemisphere Ventures Frontier Tech Fund 2019, A Series of Hemisphere Ventures, LP | | | | | 25,380 | | | | | | 25,380 | | | | | | — | | | | | | — | | |
| Mark Hilse | | | | | 5,392 | | | | | | 5,392 | | | | | | — | | | | | | — | | |
| Patrick Woodson | | | | | 1,427 | | | | | | 1,427 | | | | | | — | | | | | | — | | |
| Pmf Fund, A Series of Angel Deal Holdings, LP | | | | | 12,690 | | | | | | 12,690 | | | | | | — | | | | | | — | | |
| Scouts 2020 LLC | | | | | 3,172 | | | | | | 3,172 | | | | | | — | | | | | | — | | |
| Seachange Fund VII, LLC | | | | | 27,655 | | | | | | 27,655 | | | | | | — | | | | | | — | | |
| Stuart Gardner | | | | | 1,213 | | | | | | 1,213 | | | | | | — | | | | | | — | | |
| Thomas Eiden | | | | | 640,125 | | | | | | 640,125 | | | | | | — | | | | | | — | | |
| Thomas James | | | | | 4,497 | | | | | | 4,497 | | | | | | — | | | | | | — | | |
| Twenty Nineteen Ventures, LLC | | | | | 3,172 | | | | | | 3,172 | | | | | | — | | | | | | — | | |
| Type One Fund II, A Series of Type One Fund LP | | | | | 14,276 | | | | | | 14,276 | | | | | | — | | | | | | — | | |
| YC Holdings II, LLC | | | | | 79,959 | | | | | | 79,959 | | | | | | — | | | | | | — | | |
| | | | Page | | |||
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-7 | | | |
| | | | | F-8 | | | |
| | | | | F-9 | | | |
(in thousands, except share data)
| | | | As of December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Assets | | | | | | | | | | | | | |
| Current assets: | | | | | | | | | | | | | |
| Cash and cash equivalents | | | | $ | 97,132 | | | | | $ | 9,868 | | |
| Marketable debt securities | | | | | 130,682 | | | | | | — | | |
| Prepaid and other current assets | | | | | 4,125 | | | | | | 4,331 | | |
| Total current assets | | | | | 231,939 | | | | | | 14,199 | | |
| Marketable debt securities | | | | | 47,473 | | | | | | — | | |
| Property and equipment, net | | | | | 1,202 | | | | | | 578 | | |
| Operating lease right-of-use assets | | | | | 982 | | | | | | 83 | | |
| Other assets | | | | | 140 | | | | | | 25 | | |
| Total assets | | | | $ | 281,736 | | | | | $ | 14,885 | | |
| Liabilities and stockholders’ equity (deficit) | | | | | | | | | | | | | |
| Current liabilities: | | | | | | | | | | | | | |
| Accounts payable | | | | $ | 2,970 | | | | | $ | 2,274 | | |
| Accrued expenses and other | | | | | 1,885 | | | | | | 836 | | |
| Operating lease liabilities | | | | | 481 | | | | | | 94 | | |
| Total current liabilities | | | | | 5,336 | | | | | | 3,204 | | |
| Operating lease liabilities, net of current portion | | | | | 543 | | | | | | — | | |
| Simple agreements for future equity | | | | | — | | | | | | 46,042 | | |
| Right of first refusal liability | | | | | 25,000 | | | | | | — | | |
| Total liabilities | | | | | 30,879 | | | | | | 49,246 | | |
| Commitments and contingencies (Note 15) | | | | | | | | | | | | | |
| Stockholders’ equity (deficit): | | | | | | | | | | | | | |
| Class A common stock, $0.0001 par value – 500,000,000 shares authorized; 137,706,596 and 69,242,940 shares issued and outstanding as of December 31, 2024 and 2023, respectively | | | | | 14 | | | | | | 7 | | |
| Additional paid-in capital | | | | | 383,739 | | | | | | 27,125 | | |
| Accumulated deficit | | | | | (135,109) | | | | | | (61,493) | | |
| Accumulated other comprehensive income | | | | | 2,213 | | | | | | — | | |
| Total stockholders’ equity (deficit) | | | | | 250,857 | | | | | | (34,361) | | |
| Total liabilities and stockholders’ equity | | | | $ | 281,736 | | | | | $ | 14,885 | | |
(in thousands, except share data)
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Operating expenses | | | | | | | | | | | | | |
| Research and development | | | | $ | 26,711 | | | | | $ | 9,763 | | |
| General and administrative | | | | | 26,090 | | | | | | 8,873 | | |
| Total operating expenses | | | | | 52,801 | | | | | | 18,636 | | |
| Loss from operations | | | | | (52,801) | | | | | | (18,636) | | |
| Other income (loss) | | | | | | | | | | | | | |
| Change in fair value of simple agreements for future equity | | | | | (27,864) | | | | | | (13,717) | | |
| Interest and dividend income | | | | | 7,732 | | | | | | 180 | | |
| Total other income (loss) | | | | | (20,132) | | | | | | (13,537) | | |
| Loss before income taxes | | | | | (72,933) | | | | | | (32,173) | | |
| Income taxes | | | | | (683) | | | | | | — | | |
| Net loss | | | | $ | (73,616) | | | | | $ | (32,173) | | |
| Net loss per share: | | | | | | | | | | | | | |
| Basic and diluted – Class A common stock | | | | $ | (0.74) | | | | | $ | (0.47) | | |
| Weighted-average common shares outstanding – basic and diluted – Class A common stock | | | | | 98,910,013 | | | | | | 68,891,996 | | |
(in thousands)
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Net loss | | | | $ | (73,616) | | | | | $ | (32,173) | | |
| Other comprehensive income: | | | | | | | | | | | | | |
| Change in unrealized gains on marketable debt securities | | | | | 2,213 | | | | | | — | | |
| Total comprehensive loss | | | | $ | (71,403) | | | | | $ | (32,173) | | |
(in thousands, except share data)
| | | | Redeemable Convertible Preferred Stock | | | | Common Stock | | | Class A Common Stock | | | Additional Paid-in Capital | | | Accumulated Deficit | | | Accumulated Other Comprehensive Income | | | Total Stockholders’ Equity | | |||||||||||||||||||||||||||||||||||||||
| | | | Shares | | | Amount | | | | Shares(1) | | | Par Value(1) | | | Shares | | | Par Value | | ||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2023, as recast | | | | | — | | | | | $ | — | | | | | | | — | | | | | $ | — | | | | | | 69,242,940 | | | | | $ | 7 | | | | | $ | 27,125 | | | | | $ | (61,493) | | | | | $ | — | | | | | $ | (34,361) | | |
| Exercise of stock options | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 2,256,157 | | | | | | — | | | | | | 1,044 | | | | | | — | | | | | | — | | | | | | 1,044 | | |
| Stock-based compensation | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 12,484 | | | | | | — | | | | | | — | | | | | | 12,484 | | |
| Issuance of Class A common stock in connection with the Business Combination, net of transaction costs (Note 3) | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 43,099,811 | | | | | | 4 | | | | | | 258,951 | | | | | | — | | | | | | — | | | | | | 258,955 | | |
| Issuance of Class A common stock upon conversion of simple agreements for future equity immediately before the Business Combination (Note 3) | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 8,407,894 | | | | | | 1 | | | | | | 84,137 | | | | | | — | | | | | | — | | | | | | 84,138 | | |
| Change in unrealized gains on marketable debt securities | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,213 | | | | | | 2,213 | | |
| Issuance of Class A common stock in connection with earnout awards | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 14,699,794 | | | | | | 2 | | | | | | (2) | | | | | | — | | | | | | — | | | | | | — | | |
| Net loss | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (73,616) | | | | | | — | | | | | | (73,616) | | |
| Balance as of December 31, 2024 | | | | | — | | | | | $ | — | | | | | | $ | — | | | | | $ | — | | | | | | 137,706,596 | | | | | $ | 14 | | | | | $ | 383,739 | | | | | $ | (135,109) | | | | | $ | 2,213 | | | | | $ | 250,857 | | |
(in thousands, except share data)
| | | | Redeemable Convertible Preferred Stock | | | | Common Stock | | | Class A Common Stock | | | Additional Paid-in Capital | | | Accumulated Deficit | | | Accumulated Other Comprehensive Income | | | Total Stockholders’ Equity | | |||||||||||||||||||||||||||||||||||||||
| | | | Shares | | | Amount | | | | Shares(1) | | | Par Value(1) | | | Shares | | | Par Value | | ||||||||||||||||||||||||||||||||||||||||||
| Balance as of January 1, 2023, as previously reported | | | | | 6,585,881 | | | | | $ | 25,032 | | | | | | | 4,771,025 | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | 1,209 | | | | | $ | (29,320) | | | | | $ | — | | | | | $ | (28,111) | | |
| Retroactive application of reverse recapitalization (Note 3) | | | | | (6,585,881) | | | | | | (25,032) | | | | | | | (4,771,025) | | | | | | — | | | | | | 68,845,564 | | | | | | 7 | | | | | | 25,025 | | | | | | — | | | | | | — | | | | | | 25,032 | | |
| Balance as of January 1, 2023, after effect of reverse recapitalization | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 68,845,564 | | | | | | 7 | | | | | | 26,234 | | | | | | (29,320) | | | | | | — | | | | | | (3,079) | | |
| Exercise of stock options | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 397,376 | | | | | | — | | | | | | 114 | | | | | | — | | | | | | — | | | | | | 114 | | |
| Stock-based compensation | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 777 | | | | | | — | | | | | | — | | | | | | 777 | | |
| Net loss | | | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (32,173) | | | | | | — | | | | | | (32,173) | | |
| Balance as of December 31, 2023 | | | | | — | | | | | $ | — | | | | | | | — | | | | | $ | — | | | | | | 69,242,940 | | | | | $ | 7 | | | | | $ | 27,125 | | | | | $ | (61,493) | | | | | $ | — | | | | | $ | (34,361) | | |
(in thousands)
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Cash flows from operating activities | | | | | | | | | | | | | |
| Net loss | | | | $ | (73,616) | | | | | $ | (32,173) | | |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | |
| Depreciation and amortization | | | | | 268 | | | | | | 75 | | |
| Change in fair value of simple agreements for future equity | | | | | 27,864 | | | | | | 13,717 | | |
| Accretion of discount on marketable debt securities | | | | | (520) | | | | | | — | | |
| Stock-based compensation | | | | | 12,484 | | | | | | 777 | | |
| Change in operating assets and liabilities: | | | | | | | | | | | | | |
| Prepaid and other current assets | | | | | (1,520) | | | | | | (126) | | |
| Other assets | | | | | (115) | | | | | | 26 | | |
| Accounts payable | | | | | (1,762) | | | | | | 1,344 | | |
| Accrued expenses and other | | | | | (1,504) | | | | | | 384 | | |
| Operating lease right-of-use assets and liabilities | | | | | 31 | | | | | | (22) | | |
| Net cash used in operating activities | | | | | (38,390) | | | | | | (15,998) | | |
| Cash flows from investing activities | | | | | | | | | | | | | |
| Purchases of property and equipment | | | | | (352) | | | | | | (83) | | |
| Purchases of marketable debt securities | | | | | (291,620) | | | | | | — | | |
| Proceeds from redemptions of marketable debt securities | | | | | 116,198 | | | | | | — | | |
| Net cash used in investing activities | | | | | (175,774) | | | | | | (83) | | |
| Cash flows from financing activities | | | | | | | | | | | | | |
| Proceeds from recapitalization | | | | | 276,210 | | | | | | — | | |
| Proceeds from exercise of stock options | | | | | 1,044 | | | | | | 114 | | |
| Proceeds from right of first refusal liability | | | | | 25,000 | | | | | | — | | |
| Proceeds from simple agreements for future equity | | | | | 10,232 | | | | | | 19,325 | | |
| Payment of deferred issuance costs | | | | | (11,058) | | | | | | (3,144) | | |
| Net cash provided by financing activities | | | | | 301,428 | | | | | | 16,295 | | |
| Net increase in cash and cash equivalents | | | | | 87,264 | | | | | | 214 | | |
| Cash and cash equivalents – beginning of year | | | | | 9,868 | | | | | | 9,654 | | |
| Cash and cash equivalents – end of year | | | | $ | 97,132 | | | | | $ | 9,868 | | |
| Supplemental disclosures of cash flow information | | | | | | | | | | | | | |
| Cash paid for interest | | | | $ | — | | | | | $ | — | | |
| Cash paid for income taxes | | | | | 907 | | | | | | — | | |
| Supplemental noncash investing and financing activities | | | | | | | | | | | | | |
| Reclassification of deferred issuance costs in connection with business combination | | | | $ | 5,510 | | | | | $ | — | | |
| Reclassification of simple agreements for future equity in connection with business combination | | | | | 84,138 | | | | | | — | | |
| Deferred issuance costs included in accounts payable | | | | | 1,906 | | | | | | 443 | | |
| Deferred issuance costs included in accrued expense and other | | | | | — | | | | | | 122 | | |
| Purchases of computer software in accounts payable and accrued expense and other | | | | | 540 | | | | | | 392 | | |
(in thousands, except share data and amounts, and exchange ratio)
| | Furniture and fixtures | | | 7 years | |
| | Computers | | | 3 to 7 years | |
| | Software | | | 3 years | |
| | Leasehold improvements | | | Shorter of lease term or estimated useful life of the asset | |
| | Cash proceeds from recapitalization | | | | $ | 276,210 | | |
| | Add: accrued interest receivable | | | | | 44 | | |
| | Add: advance to Legacy Oklo | | | | | 1,830 | | |
| | Add: prepaid expenses | | | | | 4 | | |
| | Less: transaction costs and advisor fees paid | | | | | (14,662) | | |
| | Less: advisor fees for Earnout Shares | | | | | (1,906) | | |
| | Cash and other assets acquired from the Business Combination | | | | | 261,520 | | |
| | Less: accounts payable | | | | | (12) | | |
| | Less: accrued expenses | | | | | (45) | | |
| | Less: excise tax payable | | | | | (2,159) | | |
| | Less: income taxes payable | | | | | (349) | | |
| | Net assets from the Business Combination recorded on the consolidated stockholders’ equity (deficit) | | | | $ | 258,955 | | |
| | | | Class A Common Stock(1) | | |||
| Legacy Oklo stockholders(2) | | | | | 78,996,459 | | |
| Sponsor stockholders (as defined in Note 11)(3) | | | | | 13,950,000 | | |
| AltC public stockholders (as defined in Note 11)(4) | | | | | 29,149,811 | | |
| Total AltC stockholders | | | | | 43,099,811 | | |
| Total Class A common stock | | | | | 122,096,270 | | |
| | | | As of December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Prepaid expense | | | | $ | 2,119 | | | | | $ | 370 | | |
| Deferred issuance costs | | | | | — | | | | | | 3,710 | | |
| Costs-share receivables | | | | | 600 | | | | | | 126 | | |
| Accrued interest receivable | | | | | 1,138 | | | | | | — | | |
| Rent security | | | | | 143 | | | | | | — | | |
| Refundable deposit | | | | | 125 | | | | | | 125 | | |
| Total prepaid and other current assets | | | | $ | 4,125 | | | | | $ | 4,331 | | |
| | | | As of December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Computers and equipment | | | | $ | 366 | | | | | $ | 197 | | |
| Furniture, fixtures and machinery | | | | | 146 | | | | | | 65 | | |
| Software | | | | | 1,020 | | | | | | 392 | | |
| Leasehold improvements | | | | | 45 | | | | | | 31 | | |
| Total property and equipment, gross | | | | | 1,577 | | | | | | 685 | | |
| Less accumulated depreciation and amortization | | | | | (375) | | | | | | (107) | | |
| Total property and equipment, net | | | | $ | 1,202 | | | | | $ | 578 | | |
| | | | As of December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Accrued professional fees | | | | $ | 652 | | | | | $ | — | | |
| Accrued payroll and bonuses | | | | | 636 | | | | | | 197 | | |
| Credit card liabilities | | | | | 261 | | | | | | 156 | | |
| Franchise and income taxes payable | | | | | 202 | | | | | | — | | |
| General accrued expenses | | | | | 134 | | | | | | 483 | | |
| Total accrued expenses and other | | | | $ | 1,885 | | | | | $ | 836 | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Operating lease costs during the year | | | | $ | 321 | | | | | $ | 340 | | |
| Cash payments included in the measurement of operating lease liabilities during the year | | | | $ | 289 | | | | | $ | 225 | | |
| Operating lease liabilities arising from obtaining lease right-of-use assets during the year | | | | $ | 1,185 | | | | | $ | — | | |
| Weighted-average remaining lease term (in months) as of year-end | | | | | 24 | | | | | | 5 | | |
| Weighted-average discount rate during the year | | | | | 8.76% | | | | | | 6.85% | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Operating lease costs: | | | | | | | | | | | | | |
| Research and development | | | | $ | 234 | | | | | $ | 210 | | |
| Sales, general and administrative | | | | | 87 | | | | | | 130 | | |
| Total operating lease costs(1) | | | | $ | 321 | | | | | $ | 340 | | |
| | 2025 | | | | $ | 548 | | |
| | 2026 | | | | | 566 | | |
| | Minimum lease payments | | | | | 1,114 | | |
| | Less imputed interest | | | | | (90) | | |
| | Present value of operating lease liabilities | | | | $ | 1,024 | | |
| | Current portion of operating lease liabilities | | | | $ | 481 | | |
| | Noncurrent portion of operating lease liabilities | | | | | 543 | | |
| | Total operating lease liabilities | | | | $ | 1,024 | | |
| | | | Amortized Cost(1) | | | Unrealized Gains | | | Unrealized Losses | | | Fair Value | | | Cash and Cash Equivalents | | | Current Marketable Securities | | | Noncurrent Marketable Securities | | |||||||||||||||||||||
| Cash | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 3,020 | | | | | $ | — | | | | | $ | — | | |
| Level 1: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Money market funds | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 94,112 | | | | | | — | | | | | | — | | |
| U.S. Treasury securities | | | | | 156,040 | | | | | | 1,688 | | | | | | (6) | | | | | | 157,722 | | | | | | — | | | | | | 110,249 | | | | | | 47,473 | | |
| Subtotal | | | | | 156,040 | | | | | | 1,688 | | | | | | (6) | | | | | | 157,722 | | | | | | 94,112 | | | | | | 110,249 | | | | | | 47,473 | | |
| Level 2(2): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Commercial paper | | | | | 19,902 | | | | | | 531 | | | | | | — | | | | | | 20,433 | | | | | | — | | | | | | 20,433 | | | | | | — | | |
| Total | | | | $ | 175,942 | | | | | $ | 2,219 | | | | | $ | (6) | | | | | $ | 178,155 | | | | | $ | 97,132 | | | | | $ | 130,682 | | | | | $ | 47,473 | | |
| | Due within 1 year | | | | $ | 130,682 | | |
| | Due after 1 year through 5 years | | | | | 47,473 | | |
| | Total fair value | | | | $ | 178,155 | | |
| Legacy Oklo SAFEs | | | Outstanding Principal Balance of SAFEs Before Closing | | | Legacy Oklo Price Per Share Upon Conversion | | | Legacy Oklo Common Stock Issuable | | | Exchange Ratio | | | Class A Common Stock Issued at Closing(1) | | |||||||||||||||
| Valuation cap of $300,000,000 | | | | $ | 13,995 | | | | | $ | 22.445945 | | | | | | 623,487 | | | | | | 6.062 | | | | | | 3,779,578 | | |
| Valuation cap of $500,000,000 | | | | | 28,562 | | | | | | 37.409909 | | | | | | 763,496 | | | | | | 6.062 | | | | | | 4,628,316 | | |
| Total | | | | $ | 42,557 | | | | | | | | | | | | 1,386,983 | | | | | | | | | | | | 8,407,894 | | |
| | Asset volatility(1) | | | 85.8% | |
| | Risk-free rate(2) | | | 3.8% | |
| | Expected term(3) | | | 60 months | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Beginning balance | | | | $ | 46,042 | | | | | $ | 13,340 | | |
| SAFEs issued during the period | | | | | 10,232 | | | | | | 18,985 | | |
| Change in fair value during the period(1) | | | | | 27,864 | | | | | | 13,717 | | |
| Change in fair value upon conversion on SAFEs at Closing | | | | | (84,138) | | | | | | — | | |
| Ending balance | | | | $ | — | | | | | $ | 46,042 | | |
| Preferred Stock Series | | | Shares Issued and Outstanding Before Closing(1) | | | Exchange Ratio | | | Class A Common Stock Issued at Closing(1) | | |||||||||
| Preferred Stock Series A-1 | | | | | 4,526,703 | | | | | | 6.062 | | | | | | 27,440,874 | | |
| Preferred Stock Series A-2 | | | | | 55,135 | | | | | | 6.062 | | | | | | 334,228 | | |
| Preferred Stock Series A-3 | | | | | 2,004,043 | | | | | | 6.062 | | | | | | 12,148,509 | | |
| Totals | | | | | 6,585,881 | | | | | | | | | | | | 39,923,611 | | |
| | | | Years Ended December 31, | | |||
| | | | 2024 | | | 2023 | |
| Expected volatility | | | 79.67% | | | 75.63% – 78.47% | |
| Expected dividend yield | | | 0% | | | 0% | |
| Risk-free interest rate | | | 4.08% | | | 3.64% – 4.87% | |
| Expected term | | | 6.3 years | | | 6.3 years | |
| | | | Number of Shares | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Life (in years) | | |||||||||
| Class A common stock awards outstanding at January 1, 2024 | | | | | 11,426,653 | | | | | $ | 1.59 | | | | | | 8.47 | | |
| Granted | | | | | 351,717 | | | | | | 4.37 | | | | | | | | |
| Exercised | | | | | (2,256,157) | | | | | | 0.46 | | | | | | | | |
| Forfeited | | | | | (51,831) | | | | | | 3.18 | | | | | | | | |
| Class A common stock awards outstanding at December 31, 2024 | | | | | 9,470,382 | | | | | | 1.95 | | | | | | 7.91 | | |
| Class A common stock awards exercisable at December 31, 2024 | | | | | 3,256,613 | | | | | | 1.29 | | | | | | 6.96 | | |
| Class A common stock awards not vested at December 31, 2024 | | | | | 6,213,769 | | | | | | | | | | | | | | |
| | | | Number of Units | | | Weighted Average Grant Date Fair Value | | ||||||||||||
| | | | Unvested | | | Vested | | ||||||||||||
| Restricted stock units, beginning balance | | | | | — | | | | | | — | | | | | | — | | |
| Granted | | | | | 1,390,298 | | | | | | — | | | | | | 8.02 | | |
| Vested | | | | | (134,832) | | | | | | 134,832 | | | | | | 7.78 | | |
| Forfeited | | | | | (3,300) | | | | | | — | | | | | | 7.46 | | |
| Restricted stock units outstanding at December 31, 2024 | | | | | 1,252,166 | | | | | | 134,832 | | | | | | 8.02 | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Research and development | | | | $ | 7,797 | | | | | $ | 398 | | |
| General and administrative | | | | | 4,687 | | | | | | 379 | | |
| Total costs charged to operations(1) | | | | $ | 12,484 | | | | | $ | 777 | | |
| | | | As at December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Deferred tax assets: | | | | | | | | | | | | | |
| Net operating loss carryforwards | | | | $ | 3,078 | | | | | $ | 2,320 | | |
| R&D credit | | | | | 2,443 | | | | | | 1,424 | | |
| Capitalized R&D expenses | | | | | 5,617 | | | | | | 2,647 | | |
| Capitalized start-up expenses | | | | | 15,628 | | | | | | 4,652 | | |
| Operating lease liabilities | | | | | 216 | | | | | | — | | |
| Stock-based compensation | | | | | 394 | | | | | | 80 | | |
| Depreciation and amortization | | | | | 73 | | | | | | 17 | | |
| Accrued expenses | | | | | — | | | | | | 44 | | |
| Deferred tax assets | | | | | 27,449 | | | | | | 11,184 | | |
| Valuation allowance | | | | | (26,775) | | | | | | (11,184) | | |
| Total deferred tax assets | | | | | 674 | | | | | | — | | |
| Deferred tax liabilities: | | | | | | | | | | | | | |
| Right-of-use assets | | | | | (207) | | | | | | — | | |
| Unrealized gain on marketable securities | | | | | (467) | | | | | | — | | |
| Total deferred tax liabilities | | | | | (674) | | | | | | — | | |
| Net deferred assets | | | | $ | — | | | | | $ | — | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Federal taxes at statutory rate | | | | | 21.0% | | | | | | 21.0% | | |
| State and local taxes, net of federal benefit | | | | | (0.7)% | | | | | | 0.2% | | |
| Tax credit carryforward generated | | | | | 1.8% | | | | | | 1.9% | | |
| Change in unrealized gains on marketable securities | | | | | (0.6)% | | | | | | 0.0% | | |
| Valuation allowance | | | | | (21.4)% | | | | | | (13.7)% | | |
| Nondeductible change in fair value of SAFE | | | | | (8.0)% | | | | | | (9.0)% | | |
| Transaction costs | | | | | 2.1% | | | | | | 0.0% | | |
| Interest expense | | | | | 1.6% | | | | | | 0.0% | | |
| Stock-based compensation | | | | | 3.8% | | | | | | 0.0% | | |
| Other differences | | | | | (0.5)% | | | | | | (0.4)% | | |
| Effective Income Tax Rate | | | | | (0.9)% | | | | | | 0.0% | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Valuation allowance for deferred tax assets – beginning of year | | | | $ | 11,184 | | | | | $ | 6,777 | | |
| Change in valuation allowance for deferred tax assets during the year | | | | | 15,591 | | | | | | 4,407 | | |
| Valuation allowance for deferred tax assets – end of year | | | | $ | 26,775 | | | | | $ | 11,184 | | |
| | | | Years Ended December 31, | | |||||||||
| | | | 2024 | | | 2023 | | ||||||
| Balance at beginning of year | | | | $ | — | | | | | $ | — | | |
| Additions for tax positions taken in prior year | | | | | 142 | | | | | | — | | |
| Additions for tax positions related to the current year | | | | | 129 | | | | | | — | | |
| Balance at end of year | | | | $ | 271 | | | | | $ | — | | |
| | SEC Registration Fee | | | | $ | 4,250.49 | | |
| | FINRA Filing Fees | | | | $ | ** | | |
| | Legal Fees and Expenses | | | | $ | ** | | |
| | Accounting Fees and Expenses | | | | $ | ** | | |
| | Miscellaneous Expenses | | | | $ | ** | | |
| | Total | | | | $ | ** | | |
| | Exhibit Number | | | Description | |
| | 10.12 | | | Confidential Letter of Intent to Purchase Power, dated as of February 16, 2024, by and between Oklo Inc. and Equinix, Inc. (incorporated by reference to Exhibit 10.19 to the Company’s Registration Statement on Form S-4, as amended, filed by the registrant with the SEC on April 15, 2024). | |
| | 21.1 | | | | |
| | 23.1* | | | | |
| | 23.2* | | | | |
| | 24.1* | | | | |
| | 101.INS | | | XBRL Instance Document | |
| | 101.SCH | | | XBRL Taxonomy Extension Schema Document | |
| | 101.CAL | | | XBRL Taxonomy Extension Calculation Linkbase Document | |
| | 101.DEF | | | XBRL Taxonomy Extension Definition Linkbase Document | |
| | 101.LAB | | | XBRL Taxonomy Extension Label Linkbase Document | |
| | 104 | | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
| | 107* | | | |
Chief Executive Officer
| | Signature | | | Title | | | Date | |
| | /s/ Jacob DeWitte Jacob DeWitte | | | Chairman and Chief Executive Officer (Principal Executive Officer) | | | May 8, 2025 | |
| | /s/ R. Craig Bealmear R. Craig Bealmear | | | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | | | May 8, 2025 | |
| | /s/ Caroline Cochran Caroline Cochran | | | Chief Operating Officer and Director | | | May 8, 2025 | |
| | /s/ John Jansen Lieutenant General (Ret.) John Jansen | | | Director | | | May 8, 2025 | |
| | /s/ Richard W. Kinzley Richard W. Kinzley | | | Director | | | May 8, 2025 | |
| | /s/ Michael Klein Michael Klein | | | Director | | | May 8, 2025 | |
| | /s/ Michael Thompson Michael Thompson | | | Director | | | May 8, 2025 | |
| | /s/ Daniel Poneman Daniel Poneman | | | Director | | | May 8, 2025 | |